Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
During the following 26 weeks of treatment (extension phase), discontinuations as a result of adverse events occurred in 2.4% of patients in the T-T group (patients treated with tesamorelin for Week 0-26 and with tesamorelin for Week 26-52) and 5.2% of patients in the T-P group (patients treated with tesamorelin for Week 0-26 and with placebo for Week 26-52)
New blood vessel formation delivers more oxygen and nutrients to healing tissue while removing metabolic waste products
:max_bytes(150000):strip_icc()/Health-GettyImages-2242656837-7ba7eeb1b08d43c681f154b32e6dc07c.jpg)
People with acne may notice clearer skin
8 (bvae163), 013 (2024)
Unlike intravenous injections, subcutaneous injections deposit medication into the tissue layer between skin and muscle
